Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
White House announces signing of medical marijuana research expansion act » 13:49
12/02/22
12/02
13:49
12/02/22
13:49
ACB

Aurora Cannabis

$1.35 /

+0.035 (+2.66%)

, CGC

Canopy Growth

$4.15 /

+0.225 (+5.73%)

, IGC

India Globalization Capital

/

+

, CANN

General Cannabis

/

+

, ZYNE

Zynerba

/

+

, CRON

Cronos Group

$3.37 /

+0.1 (+3.06%)

, TLRY

Tilray

$4.30 /

+0.115 (+2.75%)

, CVSI

CV Sciences

/

+

, CNTTF

CannTrust Holdings

/

+

, GTBIF

Green Thumb Industries

$14.52 /

+1.52 (+11.69%)

, TCNNF

Trulieve Cannabis

$13.80 /

+0.91 (+7.06%)

, GDNSF

Goodness Growth

/

+

On Friday, December 2,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$1.35 /

+0.035 (+2.66%)

CGC Canopy Growth
$4.15 /

+0.225 (+5.73%)

IGC India Globalization Capital
/

+

CANN General Cannabis
/

+

ZYNE Zynerba
/

+

CRON Cronos Group
$3.37 /

+0.1 (+3.06%)

TLRY Tilray
$4.30 /

+0.115 (+2.75%)

CVSI CV Sciences
/

+

CNTTF CannTrust Holdings
/

+

GTBIF Green Thumb Industries
$14.52 /

+1.52 (+11.69%)

TCNNF Trulieve Cannabis
$13.80 /

+0.91 (+7.06%)

GDNSF Goodness Growth
/

+

ACB Aurora Cannabis
$1.35 /

+0.035 (+2.66%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CGC Canopy Growth
$4.15 /

+0.225 (+5.73%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
IGC India Globalization Capital
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CANN General Cannabis
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
ZYNE Zynerba
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CRON Cronos Group
$3.37 /

+0.1 (+3.06%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
TLRY Tilray
$4.30 /

+0.115 (+2.75%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
CVSI CV Sciences
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CNTTF CannTrust Holdings
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
GTBIF Green Thumb Industries
$14.52 /

+1.52 (+11.69%)

12/01/22 Wedbush
Wedbush starts Green Thumb with Outperform, names top cannabis pick
12/01/22 Wedbush
Green Thumb Industries initiated with an Outperform at Wedbush
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
TCNNF Trulieve Cannabis
$13.80 /

+0.91 (+7.06%)

12/01/22 Wedbush
Wedbush starts Trulieve with Outperform on broadening reach
12/01/22 Wedbush
Trulieve Cannabis initiated with an Outperform at Wedbush
11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
ACB Aurora Cannabis
$1.35 /

+0.035 (+2.66%)

CGC Canopy Growth
$4.15 /

+0.225 (+5.73%)

ZYNE Zynerba
/

+

CRON Cronos Group
$3.37 /

+0.1 (+3.06%)

TLRY Tilray
$4.30 /

+0.115 (+2.75%)

  • 27
    May
ACB Aurora Cannabis
$1.35 /

+0.035 (+2.66%)

CGC Canopy Growth
$4.15 /

+0.225 (+5.73%)

IGC India Globalization Capital
/

+

CANN General Cannabis
/

+

ZYNE Zynerba
/

+

CRON Cronos Group
$3.37 /

+0.1 (+3.06%)

TLRY Tilray
$4.30 /

+0.115 (+2.75%)

CVSI CV Sciences
/

+

GTBIF Green Thumb Industries
$14.52 /

+1.52 (+11.69%)

TCNNF Trulieve Cannabis
$13.80 /

+0.91 (+7.06%)

GDNSF Goodness Growth
/

+

ACB Aurora Cannabis
$1.35 /

+0.035 (+2.66%)

CGC Canopy Growth
$4.15 /

+0.225 (+5.73%)

TLRY Tilray
$4.30 /

+0.115 (+2.75%)

Yesterday
On The Fly
Here's What You Missed in Cannabis This Week » 10:47
12/01/22
12/01
10:47
12/01/22
10:47
HITI

High Tide

$1.85 /

-0.02 (-1.07%)

, IGC

India Globalization Capital

/

+

, CGC

Canopy Growth

$3.66 /

+0.03 (+0.83%)

, ETRGF

Entourage Health

/

+

, PLNHF

Planet 13 Holdings

$1.35 /

-0.02 (-1.46%)

, GNLN

Greenlane

/

+

, ACB

Aurora Cannabis

$1.28 /

+0.01 (+0.79%)

, CVSI

CV Sciences

/

+

, CRON

Cronos Group

$3.19 /

+0.085 (+2.74%)

, CTST

CannTrust

/

+

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$13.00 /

+0.3 (+2.36%)

, TLRY

Tilray

$3.93 /

+0.08 (+2.08%)

, TCNNF

Trulieve Cannabis

$12.89 /

-0.07 (-0.54%)

, ZYNE

Zynerba

/

+

, RLMD

Relmada Therapeutics

$4.69 /

+0.05 (+1.08%)

, ATAI

Atai Life Sciences

$3.36 /

-0.15 (-4.27%)

, CMPS

Compass Pathways

$10.17 /

-0.15 (-1.45%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

TCNNF Trulieve Cannabis
$12.89 /

-0.07 (-0.54%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.85 /

-0.02 (-1.07%)

GTBIF Green Thumb Industries
$13.00 /

+0.3 (+2.36%)

GNLN Greenlane
/

+

GDNSF Goodness Growth
/

+

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

CANN General Cannabis
/

+

ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

HITI High Tide
$1.85 /

-0.02 (-1.07%)

01/31/22 Desjardins
High Tide price target lowered to C$11.50 from C$13.50 at Desjardins
IGC India Globalization Capital
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
ETRGF Entourage Health
/

+

06/02/22 Canaccord
Entourage Health downgraded to Hold from Speculative Buy at Canaccord
PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

GNLN Greenlane
/

+

11/16/22 Alliance Global Partners
Greenlane price target lowered to $2 from $6 at Alliance Global Partners
11/01/22 Roth Capital
Greenlane downgraded to Neutral from Buy at Roth Capital
08/17/22 Alliance Global Partners
Greenlane price target raised to $6 from $1.50 at Alliance Global Partners
08/17/22 Canaccord
Greenlane price target lowered to $5 from $20 at Canaccord
ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CVSI CV Sciences
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CTST CannTrust
/

+

CANN General Cannabis
/

+

GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$13.00 /

+0.3 (+2.36%)

12/01/22 Wedbush
Wedbush starts Green Thumb with Outperform, names top cannabis pick
12/01/22 Wedbush
Green Thumb Industries initiated with an Outperform at Wedbush
11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
TLRY Tilray
$3.93 /

+0.08 (+2.08%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TCNNF Trulieve Cannabis
$12.89 /

-0.07 (-0.54%)

12/01/22 Wedbush
Wedbush starts Trulieve with Outperform on broadening reach
12/01/22 Wedbush
Trulieve Cannabis initiated with an Outperform at Wedbush
11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
ZYNE Zynerba
/

+

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

HITI High Tide
$1.85 /

-0.02 (-1.07%)

GNLN Greenlane
/

+

ETRGF Entourage Health
/

+

CRON Cronos Group
$3.19 /

+0.085 (+2.74%)

CMPS Compass Pathways
$10.17 /

-0.15 (-1.45%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ATAI Atai Life Sciences
$3.36 /

-0.15 (-4.27%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

  • 27
    May
  • 09
    Dec
PLNHF Planet 13 Holdings
$1.35 /

-0.02 (-1.46%)

IGC India Globalization Capital
/

+

HITI High Tide
$1.85 /

-0.02 (-1.07%)

ETRGF Entourage Health
/

+

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

TLRY Tilray
$3.93 /

+0.08 (+2.08%)

RLMD Relmada Therapeutics
$4.69 /

+0.05 (+1.08%)

CGC Canopy Growth
$3.66 /

+0.03 (+0.83%)

ACB Aurora Cannabis
$1.28 /

+0.01 (+0.79%)

Over a week ago
On The Fly
Rising High: Exclusive talk with cannabis REIT NewLake Capital » 09:46
11/25/22
11/25
09:46
11/25/22
09:46
NLCP

NewLake Capital Partners

$17.96 /

+1.16 (+6.90%)

, AYRWF

Ayr Wellness

$2.91 /

+0.044 (+1.53%)

, CURLF

Curaleaf

$6.70 /

+0.114 (+1.73%)

, ACB

Aurora Cannabis

$1.32 /

+ (+0.00%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$3.50 /

+0.01 (+0.29%)

, CRON

Cronos Group

$3.05 /

-0.02 (-0.65%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$13.29 /

+0.39 (+3.02%)

, IGC

India Globalization Capital

/

+

, TLRY

Tilray

$3.75 /

-0.025 (-0.66%)

, TCNNF

Trulieve Cannabis

$13.00 /

+0.82 (+6.73%)

, ZYNE

Zynerba

/

+

, ATAI

Atai Life Sciences

$3.16 /

-0.015 (-0.47%)

, CMPS

Compass Pathways

$10.48 /

-0.1 (-0.95%)

, RLMD

Relmada Therapeutics

$5.33 /

+0.09 (+1.72%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

TCNNF Trulieve Cannabis
$13.00 /

+0.82 (+6.73%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$13.29 /

+0.39 (+3.02%)

GDNSF Goodness Growth
/

+

CVSI CV Sciences
/

+

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

CANN General Cannabis
/

+

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

10/06/22 Ladenburg
NewLake Capital price target lowered to $27.50 from $29 at Ladenburg
08/09/22 Ladenburg
NewLake Capital Partners price target lowered to $29.50 from $38 at Ladenburg
03/21/22 Ladenburg
NewLake Capital price target lowered to $39.50 from $44 at Ladenburg
AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

10/28/22 BTIG
Ayr Wellness initiated with a Buy at BTIG
08/19/22 Canaccord
Ayr Wellness price target lowered to C$30 from C$40 at Canaccord
08/19/22 Northland
Ayr Wellness price target lowered to $10 from $14 at Northland
08/19/22 Canaccord
Ayr Wellness price target lowered to C$30 from C$40 at Canaccord
CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CVSI CV Sciences
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CTST CannTrust
/

+

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CANN General Cannabis
/

+

GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$13.29 /

+0.39 (+3.02%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
IGC India Globalization Capital
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TCNNF Trulieve Cannabis
$13.00 /

+0.82 (+6.73%)

11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
ZYNE Zynerba
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

  • 27
    May
  • 09
    Dec
CVSI CV Sciences
/

+

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

On The Fly
Here's What You Missed in Cannabis This Week » 11:03
11/17/22
11/17
11:03
11/17/22
11:03
RLMD

Relmada Therapeutics

$5.77 /

+ (+0.00%)

, CMPS

Compass Pathways

$10.06 /

-0.235 (-2.28%)

, ATAI

Atai Life Sciences

$2.75 /

-0.125 (-4.35%)

, ZYNE

Zynerba

/

+

, TCNNF

Trulieve Cannabis

$12.95 /

+0.45 (+3.60%)

, TLRY

Tilray

$4.00 /

-0.09 (-2.20%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$14.25 /

+ (+0.00%)

, GDNSF

Goodness Growth

/

+

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$2.92 /

-0.025 (-0.85%)

, CGC

Canopy Growth

$3.99 /

-0.085 (-2.09%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$1.40 /

-0.05 (-3.46%)

, FLGC

Flora Growth

/

+

, GRWG

GrowGeneration

$6.54 /

-0.07 (-1.06%)

, INCR

InterCure

$4.90 /

-0.21 (-4.11%)

, OGI

Organigram

$1.02 /

+0.005 (+0.50%)

, KHRNF

Khiron Life Sciences

/

+

, ETRGF

Entourage Health

/

+

, HEXO

Hexo

/

+

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$4.00 /

-0.09 (-2.20%)

TCNNF Trulieve Cannabis
$12.95 /

+0.45 (+3.60%)

RLMD Relmada Therapeutics
$5.77 /

+ (+0.00%)

OGI Organigram
$1.02 /

+0.005 (+0.50%)

INCR InterCure
$4.90 /

-0.21 (-4.11%)

IGC India Globalization Capital
/

+

HEXO Hexo
/

+

GTBIF Green Thumb Industries
$14.25 /

+ (+0.00%)

GRWG GrowGeneration
$6.54 /

-0.07 (-1.06%)

GDNSF Goodness Growth
/

+

FLGC Flora Growth
/

+

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.92 /

-0.025 (-0.85%)

CMPS Compass Pathways
$10.06 /

-0.235 (-2.28%)

CGC Canopy Growth
$3.99 /

-0.085 (-2.09%)

CANN General Cannabis
/

+

ATAI Atai Life Sciences
$2.75 /

-0.125 (-4.35%)

ACB Aurora Cannabis
$1.40 /

-0.05 (-3.46%)

RLMD Relmada Therapeutics
$5.77 /

+ (+0.00%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
CMPS Compass Pathways
$10.06 /

-0.235 (-2.28%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
ATAI Atai Life Sciences
$2.75 /

-0.125 (-4.35%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
ZYNE Zynerba
/

+

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
TCNNF Trulieve Cannabis
$12.95 /

+0.45 (+3.60%)

11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
TLRY Tilray
$4.00 /

-0.09 (-2.20%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$14.25 /

+ (+0.00%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$2.92 /

-0.025 (-0.85%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CGC Canopy Growth
$3.99 /

-0.085 (-2.09%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$1.40 /

-0.05 (-3.46%)

09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
FLGC Flora Growth
/

+

10/24/22 Alliance Global Partners
Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners
09/23/22 Alliance Global Partners
Flora Growth initiated with a Buy at Alliance Global Partners
08/01/22 Cantor Fitzgerald
Cantor starts Flora Growth with Neutral amid diversification process
08/01/22 Cantor Fitzgerald
Flora Growth initiated with a Neutral at Cantor Fitzgerald
GRWG GrowGeneration
$6.54 /

-0.07 (-1.06%)

11/08/22 Alliance Global Partners
GrowGeneration price target lowered to C$4 from C$4.50 at Alliance Global
08/05/22 Alliance Global Partners
GrowGeneration downgraded to Neutral from Buy at Alliance Global Partners
05/12/22 Oppenheimer
GrowGeneration price target lowered to $15 from $50 at Oppenheimer
05/11/22 Wells Fargo
GrowGeneration price target lowered to $4 from $8 at Wells Fargo
INCR InterCure
$4.90 /

-0.21 (-4.11%)

05/17/22 Canaccord
InterCure upgraded to Buy from Speculative Buy at Canaccord
OGI Organigram
$1.02 /

+0.005 (+0.50%)

07/15/22 Stifel
Organigram price target lowered to C$1.50 from C$2.25 at Stifel
07/15/22 Alliance Global Partners
Organigram price target lowered to C$1.50 from C$2.25 at Alliance Global
01/13/22 Stifel
Organigram price target lowered to C$2.25 from C$2.75 at Stifel
01/12/22 Canaccord
Organigram upgraded to Speculative Buy from Hold at Canaccord
KHRNF Khiron Life Sciences
/

+

ETRGF Entourage Health
/

+

06/02/22 Canaccord
Entourage Health downgraded to Hold from Speculative Buy at Canaccord
11/18/21 Canaccord
Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord
HEXO Hexo
/

+

06/16/22 Canaccord
Hexo downgraded to Hold at Canaccord on faltering turnaround prospects
06/15/22 Canaccord
Hexo downgraded to Hold from Speculative Buy at Canaccord
06/15/22 Alliance Global Partners
Hexo downgraded to Neutral from Buy at Alliance Global Partners
06/15/22 Canaccord
Tilray price target lowered to $7 from $9 at CanaccordHexo
ZYNE Zynerba
/

+

TLRY Tilray
$4.00 /

-0.09 (-2.20%)

RLMD Relmada Therapeutics
$5.77 /

+ (+0.00%)

INCR InterCure
$4.90 /

-0.21 (-4.11%)

HEXO Hexo
/

+

GRWG GrowGeneration
$6.54 /

-0.07 (-1.06%)

ETRGF Entourage Health
/

+

CRON Cronos Group
$2.92 /

-0.025 (-0.85%)

CMPS Compass Pathways
$10.06 /

-0.235 (-2.28%)

CGC Canopy Growth
$3.99 /

-0.085 (-2.09%)

ATAI Atai Life Sciences
$2.75 /

-0.125 (-4.35%)

ACB Aurora Cannabis
$1.40 /

-0.05 (-3.46%)

  • 27
    May
  • 09
    Dec
  • 19
    Nov
ZYNE Zynerba
/

+

RLMD Relmada Therapeutics
$5.77 /

+ (+0.00%)

INCR InterCure
$4.90 /

-0.21 (-4.11%)

HEXO Hexo
/

+

FLGC Flora Growth
/

+

ETRGF Entourage Health
/

+

ACB Aurora Cannabis
$1.40 /

-0.05 (-3.46%)

TLRY Tilray
$4.00 /

-0.09 (-2.20%)

RLMD Relmada Therapeutics
$5.77 /

+ (+0.00%)

INCR InterCure
$4.90 /

-0.21 (-4.11%)

HEXO Hexo
/

+

GRWG GrowGeneration
$6.54 /

-0.07 (-1.06%)

CGC Canopy Growth
$3.99 /

-0.085 (-2.09%)

ACB Aurora Cannabis
$1.40 /

-0.05 (-3.46%)

Hot Stocks
Cronos Group appoints James Holm as CFO » 07:55
11/14/22
11/14
07:55
11/14/22
07:55
CRON

Cronos Group

$3.07 /

+0.19 (+6.61%)

Cronos Group appointed…

Cronos Group appointed James Holm as CFO, effective immediately. Holm succeeds Bob Madore, who is leaving the company. Holm most recently served as the Global VP of Finance Transformation at Vertiv, a global provider of critical digital infrastructure and continuity solutions, where he led the company's centralization, standardization and optimization to a Global Shared Service hub for finance processes. Before joining Vertiv, Holm served as Finance Leader, Finance Solutions & Process Transformation Organization at Worldpay.

ShowHide Related Items >><<
CRON Cronos Group
$3.07 /

+0.19 (+6.61%)

CRON Cronos Group
$3.07 /

+0.19 (+6.61%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CRON Cronos Group
$3.07 /

+0.19 (+6.61%)

CRON Cronos Group
$3.07 /

+0.19 (+6.61%)

On The Fly
Rising High: Exclusive talk with psychedelic biopharma firm Cybin » 11:24
11/10/22
11/10
11:24
11/10/22
11:24
TCNNF

Trulieve Cannabis

$11.45 /

+0.55 (+5.05%)

, ZYNE

Zynerba

/

+

, TLRY

Tilray

$3.81 /

+0.19 (+5.25%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$12.65 /

+0.47 (+3.86%)

, GDNSF

Goodness Growth

/

+

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$2.83 /

+0.075 (+2.73%)

, CGC

Canopy Growth

$3.52 /

+0.305 (+9.49%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$1.29 /

+0.075 (+6.17%)

, CMPS

Compass Pathways

$9.72 /

+0.71 (+7.88%)

, RLMD

Relmada Therapeutics

$5.92 /

+0.16 (+2.78%)

, ATAI

Atai Life Sciences

$2.90 /

+0.175 (+6.42%)

, CYBN

Cybin

/

+

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.81 /

+0.19 (+5.25%)

TCNNF Trulieve Cannabis
$11.45 /

+0.55 (+5.05%)

RLMD Relmada Therapeutics
$5.92 /

+0.16 (+2.78%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.65 /

+0.47 (+3.86%)

GDNSF Goodness Growth
/

+

CYBN Cybin
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.83 /

+0.075 (+2.73%)

CMPS Compass Pathways
$9.72 /

+0.71 (+7.88%)

CGC Canopy Growth
$3.52 /

+0.305 (+9.49%)

CANN General Cannabis
/

+

ATAI Atai Life Sciences
$2.90 /

+0.175 (+6.42%)

ACB Aurora Cannabis
$1.29 /

+0.075 (+6.17%)

TCNNF Trulieve Cannabis
$11.45 /

+0.55 (+5.05%)

11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
TLRY Tilray
$3.81 /

+0.19 (+5.25%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.65 /

+0.47 (+3.86%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
GDNSF Goodness Growth
/

+

10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$2.83 /

+0.075 (+2.73%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CGC Canopy Growth
$3.52 /

+0.305 (+9.49%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$1.29 /

+0.075 (+6.17%)

09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CMPS Compass Pathways
$9.72 /

+0.71 (+7.88%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$5.92 /

+0.16 (+2.78%)

10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
10/14/22 Guggenheim
Relmada downgraded to Neutral at Guggenheim after MDD study miss
ATAI Atai Life Sciences
$2.90 /

+0.175 (+6.42%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
CYBN Cybin
/

+

08/24/22 Stifel
Cybin price target lowered to C$3 from C$8.25 at Stifel
06/23/22 Canaccord
Cybin undervalued relative to market size opportunity, says Canaccord
06/10/22 Canaccord
Cybin shares remain significantly undervalued, says Canaccord
04/13/22 H.C. Wainwright
H.C. Wainwright says Cybin preclinical data show continued innovation leadership
ZYNE Zynerba
/

+

TLRY Tilray
$3.81 /

+0.19 (+5.25%)

TCNNF Trulieve Cannabis
$11.45 /

+0.55 (+5.05%)

RLMD Relmada Therapeutics
$5.92 /

+0.16 (+2.78%)

CYBN Cybin
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.83 /

+0.075 (+2.73%)

CMPS Compass Pathways
$9.72 /

+0.71 (+7.88%)

CGC Canopy Growth
$3.52 /

+0.305 (+9.49%)

ATAI Atai Life Sciences
$2.90 /

+0.175 (+6.42%)

ACB Aurora Cannabis
$1.29 /

+0.075 (+6.17%)

  • 27
    May
  • 09
    Dec
ZYNE Zynerba
/

+

TCNNF Trulieve Cannabis
$11.45 /

+0.55 (+5.05%)

RLMD Relmada Therapeutics
$5.92 /

+0.16 (+2.78%)

CMPS Compass Pathways
$9.72 /

+0.71 (+7.88%)

CGC Canopy Growth
$3.52 /

+0.305 (+9.49%)

TLRY Tilray
$3.81 /

+0.19 (+5.25%)

RLMD Relmada Therapeutics
$5.92 /

+0.16 (+2.78%)

CGC Canopy Growth
$3.52 /

+0.305 (+9.49%)

ACB Aurora Cannabis
$1.29 /

+0.075 (+6.17%)

Recommendations
Two more states legalize cannabis, $3B added to TAM, says Bernstein » 13:26
11/09/22
11/09
13:26
11/09/22
13:26
ACB

Aurora Cannabis

$1.23 /

-0.08 (-6.13%)

, CGC

Canopy Growth

$3.22 /

+0.04 (+1.26%)

, IGC

India Globalization Capital

/

+

, CANN

General Cannabis

/

+

, ZYNE

Zynerba

/

+

, CRON

Cronos Group

$2.72 /

-0.05 (-1.81%)

, TLRY

Tilray

$3.64 /

-0.16 (-4.22%)

, CVSI

CV Sciences

/

+

, CNTTF

CannTrust Holdings

/

+

, GTBIF

Green Thumb Industries

$12.18 /

+0.4 (+3.40%)

, TCNNF

Trulieve Cannabis

$10.90 /

+0.3109 (+2.94%)

, GDNSF

Goodness Growth

/

+

Bernstein analyst Nadine…

Bernstein analyst Nadine Sarwat notes that Maryland and Missouri passed cannabis legalization measures, while Arkansas, North Dakota and South Dakota rejected it. Today, 21 states -- plus DC -- have now legalized recreational cannabis and 39 states have legalized medical cannabis. The analyst believes these results add an incremental $3B to Bernstein's 2027 total addressable market, or TAM, bringing it to about $59B. That would be 13% bigger that the 2021 U.S. wine market, and just 6% smaller than the 2021 U.S. spirits market, Sarwat notes, adding that the rejection in Arkansas, North Dakota and South Dakota, however, shows that a deep political divide on cannabis remains. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.64 /

-0.16 (-4.22%)

TCNNF Trulieve Cannabis
$10.90 /

+0.3109 (+2.94%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.18 /

+0.4 (+3.40%)

GDNSF Goodness Growth
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$2.72 /

-0.05 (-1.81%)

CGC Canopy Growth
$3.22 /

+0.04 (+1.26%)

CANN General Cannabis
/

+

ACB Aurora Cannabis
$1.23 /

-0.08 (-6.13%)

ACB Aurora Cannabis
$1.23 /

-0.08 (-6.13%)

10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
CGC Canopy Growth
$3.22 /

+0.04 (+1.26%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
10/26/22 Canaccord
Acreage Holdings downgraded to Hold from Speculative Buy at Canaccord
IGC India Globalization Capital
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CANN General Cannabis
/

+

ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
CRON Cronos Group
$2.72 /

-0.05 (-1.81%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
TLRY Tilray
$3.64 /

-0.16 (-4.22%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
09/30/22 Barclays
Tilray price target lowered to $2 from $4.50 at Barclays
CVSI CV Sciences
/

+

CNTTF CannTrust Holdings
/

+

GTBIF Green Thumb Industries
$12.18 /

+0.4 (+3.40%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
TCNNF Trulieve Cannabis
$10.90 /

+0.3109 (+2.94%)

10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
08/11/22 Canaccord
Trulieve Cannabis price target lowered to C$57 from C$65 at Canaccord
08/11/22 Stifel
Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel
GDNSF Goodness Growth
/

+

10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
ZYNE Zynerba
/

+

TLRY Tilray
$3.64 /

-0.16 (-4.22%)

TCNNF Trulieve Cannabis
$10.90 /

+0.3109 (+2.94%)

CVSI CV Sciences
/

+

CRON Cronos Group
$2.72 /

-0.05 (-1.81%)

CGC Canopy Growth
$3.22 /

+0.04 (+1.26%)

ACB Aurora Cannabis
$1.23 /

-0.08 (-6.13%)

  • 27
    May
GTBIF Green Thumb Industries
$12.18 /

+0.4 (+3.40%)

CGC Canopy Growth
$3.22 /

+0.04 (+1.26%)

ACB Aurora Cannabis
$1.23 /

-0.08 (-6.13%)

TLRY Tilray
$3.64 /

-0.16 (-4.22%)

CGC Canopy Growth
$3.22 /

+0.04 (+1.26%)

ACB Aurora Cannabis
$1.23 /

-0.08 (-6.13%)

Recommendations
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord » 12:34
11/08/22
11/08
12:34
11/08/22
12:34
CRON

Cronos Group

$2.77 /

-0.01 (-0.36%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley lowered the firm's price target on Cronos Group to C$4.75 from C$5 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CRON Cronos Group
$2.77 /

-0.01 (-0.36%)

CRON Cronos Group
$2.77 /

-0.01 (-0.36%)

11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/30/22 Barclays
Cronos Group price target lowered to $3.50 from $5 at Barclays
CRON Cronos Group
$2.77 /

-0.01 (-0.36%)

CRON Cronos Group
$2.77 /

-0.01 (-0.36%)

Hot Stocks
Cronos Group on track to achieve $20-$25M in operating expense savings in 2022 » 07:37
11/07/22
11/07
07:37
11/07/22
07:37
CRON

Cronos Group

$3.08 /

+0.015 (+0.49%)

Following the decision to…

Following the decision to begin a phased exit of the wholesale beauty category in the U.S. business in the second quarter of 2022, the Company continued to reduce operating expenses in the U.S. to better align the business structure with the new strategy to focus on adult-use product formats in the direct-to-consumer channel. The Company remains on track to achieve the previously identified $20 to $25 million in operating expense savings for 2022, primarily driven by savings in sales and marketing, general and administrative, and research and development.

ShowHide Related Items >><<
CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/30/22 Barclays
Cronos Group price target lowered to $3.50 from $5 at Barclays
CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

Earnings
Cronos Group reports Q3 EPS (10c), consensus (6c) » 07:36
11/07/22
11/07
07:36
11/07/22
07:36
CRON

Cronos Group

$3.08 /

+0.015 (+0.49%)

Reports Q3 revenue…

Reports Q3 revenue $20.9M, consensus $24.7M. "Market share gains through borderless innovation and cost rationalization were key drivers to this quarter's success," said Mike Gorenstein, Chairman, President and CEO, Cronos. "Our award-winning Spinach gummy lineup, such as our SOURZ by Spinach Blue-Raspberry Watermelon gummy and new additions to the portfolio including our Spinach FEELZ DEEP DREAMZ THC:CBN gummy, continue to win in the category. Beyond edibles, we achieved new product launches in the vape category powered by rare cannabinoids like CBG and CBN, and in Israel, we continued to grow the PEACE NATURALS brand with medical patients while expanding our leading position in the country. Looking further ahead, we expect pre-roll innovation to drive our recovery in the category in the fourth quarter and 2023. While executing on our innovation pipeline, we also remain on track for the previously announced $20 to $25 million in operating expense savings for 2022," continued Mr. Gorenstein. "Importantly, we will seek additional opportunities to deliver more efficiencies in 2023. I am proud and grateful for the efforts our global team has put in this year and believe our leaner and more nimble organization provides a strong foundation for us to capitalize on the many growth opportunities ahead."

ShowHide Related Items >><<
CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
09/30/22 Barclays
Cronos Group price target lowered to $3.50 from $5 at Barclays
CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

CRON Cronos Group
$3.08 /

+0.015 (+0.49%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.